Thrombopoietin mimetics are
drugs that considerably increase
platelet production by stimulating the receptor for the hormone
thrombopoietin;
Romiplostim and
Eltrombopag are examples.[1] Thrombopoietin mimetics are a type of
thrombopoietic agents. There has been a development of a registry of
pregnant patients that were treated with these drugs.[2]
^Ronald Hoffman; Edward J. Benz, Jr.; Leslie E. Silberstein; Helen Heslop; Jeffrey Weitz; John Anastasi (2013). Hematology: Basic Principles and Practice. Elsevier Health Sciences. p. 2135.